These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15466879)

  • 1. The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.
    Nascimento MM; Suliman ME; Bruchfeld A; Hayashi SY; Manfro RC; Qureshi AR; Pecoits-Filho R; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
    Nephrol Dial Transplant; 2004 Dec; 19(12):3112-6. PubMed ID: 15466879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
    Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
    Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
    Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
    J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
    Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
    Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
    Słowik-Zyłka D
    Ann Acad Med Stetin; 2004; 50(2):5-15. PubMed ID: 16529161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
    Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
    Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum pentosidine with arterial stiffness in hemodialysis patients.
    Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T
    Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients.
    Tutal E; Sezer S; Ibis A; Bilgic A; Ozdemir N; Aldemir D; Haberal M
    Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis.
    Kitauchi T; Yoshida K; Yoneda T; Saka T; Yoshikawa M; Ozono S; Hirao Y
    Clin Exp Nephrol; 2004 Mar; 8(1):48-53. PubMed ID: 15067516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
    Ozdemir A; Yalinbaş B; Selamet U; Eres M; Murat B; Gürsu RU; Barut Y
    Nephrology (Carlton); 2005 Oct; 10(5):433-7. PubMed ID: 16221090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
    Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
    Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients.
    Nascimento MM; Bruchfeld A; Suliman ME; Hayashi SY; Pecoits-Filho R; Manfro RC; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
    Braz J Med Biol Res; 2005 May; 38(5):783-8. PubMed ID: 15917961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.
    Hricik DE; Wu YC; Schulak A; Friedlander MA
    Clin Transplant; 1996 Dec; 10(6 Pt 1):568-73. PubMed ID: 8996781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis.
    Yoshimura K; Nakano H; Yokoyama K; Nakayama M
    Clin Exp Nephrol; 2005 Jun; 9(2):158-63. PubMed ID: 15980952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravenous iron therapy for HCV-positive haemodialysis patients.
    Kahraman S; Yilmaz R; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Nephron Clin Pract; 2005; 100(3):c78-85. PubMed ID: 15824511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.